Form 4: Entrada Therapeutics Director Peter S. Kim Exercises Stock Options
SEC Form 4 Filing
Director Peter S. Kim exercised stock options of Entrada Therapeutics, Inc. on June 3, 2024, acquiring 11,918 shares at $6.06 per share.
Summary
- On June 3, 2024, Peter S. Kim, a director of Entrada Therapeutics, Inc., exercised stock options to acquire 11,918 shares of common stock at a price of $6.06 per share.
- Following the transaction, Kim directly owns 104,330 shares of Entrada Therapeutics common stock.
- The stock options exercised were fully vested as of June 2, 2023, and were set to expire on June 2, 2032.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company directors. It's common for directors to exercise stock options as part of their compensation.
Key Dates
| Date | Description |
|---|---|
| 06/02/2023 | Shares subject to the option fully vested |
| 06/03/2024 | Earliest transaction date; stock options exercised |
| 06/02/2032 | Expiration date of the stock options |
| 06/05/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.